Business Segments · Total revenues

Reportable Segment — Total revenues

Amgen Reportable Segment — Total revenues increased by 4.1% to $9.56B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.4%, from $8.50B to $9.56B.

Analysis

StatementSegment
First reportedQ1 2024
Last reportedQ3 2025
Rolls up toTotal Revenue
Metric ID: amgn_segment_reportable_segment_total_revenues

Historical Data

6 periods
 Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25
Value$7.45B$8.39B$8.50B$8.15B$9.18B$9.56B
QoQ Change—+12.6%+1.4%-4.2%+12.6%+4.1%
YoY Change———+9.4%+9.4%+12.4%
Range$7.45B – $9.56B
CAGR+22.1%
Avg YoY Growth+10.4%
Median YoY Growth+9.4%
Current Streak2 quarters growth

Frequently Asked Questions

What is Amgen's reportable segment — total revenues?
Amgen (AMGN) reported reportable segment — total revenues of $9.56B in Q3 2025.
How has Amgen's reportable segment — total revenues changed year-over-year?
Amgen's reportable segment — total revenues increased by 12.4% year-over-year, from $8.50B to $9.56B.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.